Berliner Boersenzeitung - Who should get paid for nature's sequenced genes?

EUR -
AED 4.115293
AFN 71.716802
ALL 91.011256
AMD 403.562021
ANG 2.005577
AOA 1028.68237
ARS 1713.195177
AUD 1.594208
AWG 2.019825
AZN 1.909415
BAM 1.957737
BBD 2.257204
BDT 139.127639
BGN 1.958565
BHD 0.423134
BIF 3363.247326
BMD 1.120569
BND 1.431761
BOB 13.588807
BRL 6.094441
BSD 1.120744
BTN 106.356015
BWP 15.483871
BYN 3.301269
BYR 21963.14421
BZD 2.25391
CAD 1.566051
CDF 2594.116673
CHF 0.923171
CLF 0.028178
CLP 1112.6354
CNY 7.464224
CNH 7.454829
COP 3607.569699
CRC 509.620086
CUC 1.120569
CUP 26.895608
CVE 110.373701
CZK 24.44637
DJF 199.147889
DKK 7.504901
DOP 67.929628
DZD 152.176216
EGP 62.45874
ERN 16.808529
ETB 180.928952
FJD 2.514224
FKP 0.83779
GBP 0.836432
GEL 2.917805
GGP 0.83779
GHS 13.056266
GIP 0.83779
GMD 82.922473
GNF 9918.812714
GTQ 8.567476
GYD 234.908685
HKD 8.792262
HNL 30.1218
HRK 7.58514
HTG 146.830501
HUF 367.479695
IDR 20320.110526
ILS 3.523696
IMP 0.83779
INR 106.361573
IQD 1698.880708
IRR 2093687.147765
ISK 136.519303
JEP 0.83779
JMD 178.085386
JOD 0.794527
JPY 176.579628
KES 145.528673
KGS 97.99227
KHR 4572.584882
KMF 494.171137
KPW 1008.51168
KRW 1494.188988
KWD 0.348688
KYD 0.93392
KZT 508.132697
LAK 25232.86367
LBP 100357.670957
LKR 372.758771
LRD 190.505918
LSL 18.676176
LTL 3.308748
LVL 0.677821
LYD 7.204095
MAD 11.019052
MDL 20.060562
MGA 5069.195923
MKD 61.640982
MMK 2353.092792
MNT 4031.674913
MOP 9.055638
MRU 45.444581
MUR 52.980907
MVR 17.313208
MWK 1942.874107
MXN 21.05179
MYR 4.547496
MZN 71.615961
NAD 18.676176
NGN 1508.812401
NIO 41.2408
NOK 10.31876
NPR 170.169424
NZD 1.98612
OMR 0.430765
PAB 1.120849
PEN 3.878837
PGK 5.100023
PHP 71.4525
PKR 310.030214
PLN 4.423165
PYG 6565.495266
QAR 4.085242
RON 5.358787
RSD 117.944123
RUB 89.982772
RWF 1654.314474
SAR 4.207062
SBD 9.029773
SCR 15.41855
SDG 674.026121
SEK 11.010935
SGD 1.432875
SHP 0.838561
SLE 25.665129
SLL 23497.767811
SOS 640.442165
SRD 42.155234
STD 23193.507231
STN 24.525029
SVC 9.805701
SYP 14569.632352
SZL 18.671138
THB 37.785986
TJS 10.315567
TMT 3.92199
TND 3.351315
TOP 2.69806
TRY 55.955484
TTD 7.598517
TWD 36.55452
TZS 2959.64354
UAH 50.831102
UGX 4762.860677
USD 1.120569
UYU 45.056183
UZS 13441.777814
VES 994.481985
VND 28914.591409
VUV 133.591345
WST 3.108346
XAF 655.957
XAG 0.022814
XAU 0.000289139815
XCD 3.028393
XCG 2.019698
XDR 0.7923
XOF 655.957
XPF 119.331742
YER 264.68232
ZAR 18.744249
ZMK 10086.465938
ZMW 22.598962
ZWL 360.822626
SSP 6437.889567
MXV 2.372651
  • CMSD

    -0.1200

    19.81

    -0.61%

  • JRI

    0.0000

    10.77

    0%

  • BCC

    -1.8200

    74.15

    -2.45%

  • CMSC

    -0.2228

    19.53

    -1.14%

  • BCE

    0.2000

    20.34

    +0.98%

  • RIO

    0.0100

    94.17

    +0.01%

  • AZN

    -2.7400

    161.47

    -1.7%

  • GSK

    -1.1800

    48.17

    -2.45%

  • RBGPF

    0.0000

    65

    0%

  • NGG

    0.8800

    75.82

    +1.16%

  • RYCEF

    -0.7300

    19.08

    -3.83%

  • BTI

    -0.4500

    54.4

    -0.83%

  • BP

    0.4700

    43.99

    +1.07%

  • RELX

    -0.0600

    33.18

    -0.18%

  • VOD

    -0.1800

    16.15

    -1.11%

Who should get paid for nature's sequenced genes?
Who should get paid for nature's sequenced genes? / Photo: Menahem KAHANA - AFP/File

Who should get paid for nature's sequenced genes?

Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.

Text size:

The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.

Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.

"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.

"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.

Much of the information comes from poor countries.

Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.

At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).

Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?

- 'Cheap and very fast' -

The issue is a complex one.

There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.

But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?

"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.

These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.

DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.

"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.

"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.

- Mandatory -

A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.

They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.

"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.

Another sticking point is access for Indigenous people and local communities to DSI funds.

Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.

But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.

With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.

The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.

Added Barber: "I think it's not going to all get solved here."

(K.Müller--BBZ)